Notice of dividend
IMMODULON THERAPEUTICS LIMITED
The administrator intends to declare a first and final dividend to unsecured creditors of Immodulon Therapeutics Limited and sets a last date for proving claims of 8 October 2026.
Notice details
- Company
- Immodulon Therapeutics Limited
- Company number
- 06223291
- Registered office
- c/o Quantuma Advisory Limited, 7th Floor, 20 St Andrew Street, London, EC4A 3AG
- Principal trading address
- 6-9 The Square, Stockley Park, Uxbridge, UB11 1FW
- Court
- High Court of Justice Business and Property Courts of England and Wales
- Case number
- CR-2024-007586
- Administrator
- Brian Milne
- Administrator address
- Third Floor, Turnberry House, 175 West George St, Glasgow, G2 2LB
- Administrator IP number
- 9381
- Date of appointment
- 13 December 2024
- Appointed by
- The directors of the Company
- Contact name
- Susan McArthur
- Contact email
- [email protected]
- Contact telephone
- 0131 659 9965
- Last date for proving
- 8 October 2026
- Prescribed part value
- £72,713.50
What this notice means
This is a formal notice published in The London Gazette relating to the company's insolvency, restructuring or closure.
Read more: What is Insolvency?.
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If IMMODULON THERAPEUTICS LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at IMMODULON THERAPEUTICS LIMITED or something similar, start the conversation early.
If your business is under pressure — creditors circling, a petition threatened, or cash running out — acting early changes the outcome. K2 has helped UK directors turn things around since 1990. Talk to us in confidence.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More other notices
Frequently asked questions
Has IMMODULON THERAPEUTICS LIMITED gone into liquidation?
The London Gazette published a Notice of dividend for IMMODULON THERAPEUTICS LIMITED (company no. 06223291) on 09 September 2026. This is a formal notice published in The London Gazette relating to the company's insolvency, restructuring or closure.
What does a Notice of dividend mean?
This is a formal notice published in The London Gazette relating to the company's insolvency, restructuring or closure.
IMMODULON THERAPEUTICS LIMITED owes me money — what can I do?
If IMMODULON THERAPEUTICS LIMITED owes you money you are a creditor in the process. The insolvency practitioner named in the notice will write to known creditors and invite claims. Unsecured creditors rank after fixed-charge holders, the costs of the insolvency, preferential creditors and floating-charge holders, so recovery depends on what is left in the estate.
I worked for IMMODULON THERAPEUTICS LIMITED — how do I claim what I am owed?
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from the company or from K2. The insolvency practitioner named in this notice should give you a case reference to claim with.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.